GenrAb, Inc.
PrivateLast Round
Seed
Apr 22, 2025
Total Funding Raised
$5.6M
Company Overview
GenrAb, Inc. is a biotechnology company that develops neuroprotective therapies by harnessing the human immune system to identify fully-human monoclonal antibodies for the treatment of neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenrAb, Inc. Comparables
Compare GenrAb, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alchemab Therapeutics | 79% | |
| Nura Bio | 76% | |
| Sanofi | 72% | |
GenrAb, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 22, 2025 |
GenrAb, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Actium Group | Seed |
| Salem Partners | Seed |
| Research Bridge Partners | Seed |
| JMS Capital | Seed |
| Green Park & Golf Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2025
Developing therapy to protect brain cells under stress, potentially treating MS and ALS.
- Apr 22, 2025
$6M round led by Actium Group
GenrAb, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GenrAb, Inc.'s valuation, stock price, and market status.